An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Apps Comparison Feb. 2021 – Best Apps for Meetings
To understand the new smart watched and other pro devices of recent focus, we should look to Silicon Valley and the quantified movement of the […]
Meet the woman found love through organ donor’s brother
Jennifer Skaggs, who was born with a rare conditio